Baiyunshan (00874.HK): Chenliji Pharmaceutical Factory received the Drug Clinical Trial Approval Notice issued upon approval by the National Medical Products Administration regarding the additional indications for Shujin Jianyao Pills.

Zhito Finance APP News: Baiyunshan (00874.HK) has issued an announcement that recently, Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company"), through its subsidiary Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd. (hereinafter referred to as "Chenliji Pharmaceutical Factory"), received the Drug Clinical Trial Approval Notice issued by the National Medical Products Administration for the additional indications of Shujin Jianyao Pills.